Insider Trading & Ownership of Third Rock Ventures III, L.P.
-
Location
-
Boston, MA
-
Summary
-
The estimated value of insider holdings of Third Rock Ventures III, L.P. is at least $281M dollars as of February 6, 2023. Third Rock Ventures III, L.P. is the 10%+ Owner of Revolution Medicines, Inc. and owns shares of Revolution Medicines, Inc. (RVMD) stock worth about $138M. Third Rock Ventures III, L.P. is the 10%+ Owner of PLIANT THERAPEUTICS, INC. and owns shares of PLIANT THERAPEUTICS, INC. (PLRX) stock worth about $68.4M. Third Rock Ventures III, L.P. is the 10%+ Owner of Nurix Therapeutics, Inc. and owns shares of Nurix Therapeutics, Inc. (NRIX) stock worth about $35.1M. Third Rock Ventures III, L.P. is the 10%+ Owner of Voyager Therapeutics, Inc. and owns shares of Voyager Therapeutics, Inc. (VYGR) stock worth about $22.8M. Third Rock Ventures III, L.P. is the 10%+ Owner of Fulcrum Therapeutics, Inc. and owns shares of Fulcrum Therapeutics, Inc. (FULC) stock worth about $14.3M. Third Rock Ventures III, L.P. is the 10%+ Owner of Jounce Therapeutics, Inc. and owns shares of Jounce Therapeutics, Inc. stock worth about $2.65M.
-
Signature
-
/s/ Kevin Gillis, Chief Operating Officer of TRV GP III, LLC, general partner of Third Rock Ventures GP III, L.P., general partner of Third Rock Ventures III, L.P.
Notify me when Third Rock Ventures III, L.P. files a new Insider Trading report.
⭐ Subscribe ⭐